Sourced from:Manufacturer Authorized Distributor
Quick Summary
Jabryus 200mg Tablet
Last updated on 31 Mar 2026 | 09:29 AM (IST)
₹61238
MRP: ₹70382.81
(You Save ₹9144.81)
28 TABLET(s) IN A BOX
Sourced from:Manufacturer Authorized Distributor
Jabryus 200mg Tablet
Salt Composition
ABROCITINIBPAP Offer
Get Tacroz Ointment and Elovera Moisturiser Free
Marketer
GLENMARK PHARMACEUTICALS LTD
13% OFF
₹61238
MRP: ₹70,382.81
Inclusive of all taxes
13% Off
Salt Composition
ABROCITINIBPAP Offer
Get Tacroz Ointment and Elovera Moisturiser Free
Marketer
GLENMARK PHARMACEUTICALS LTD
Dispatch: Today
Order In: 0h 0m 0s
0h 0m 0s
Order before timer ends to ensure your medicine is dispatched at...
Substitutes
Cibinqo 200mg Tablet
PFIZER LTD
₹ 2176.36/tablet
75% cheaper
Introduction to Jabryus 200mg Tablet
Jabryus 200mg Tablet contains an active ingredient known as Abrocitinib that belongs to a class of Janus kinase inhibitors. It is used to improve skin conditions and reduce itchiness. It helps to improve sleep disturbance due to itchiness and overall quality of life. It aids in improving the symptoms of anxiety and depression associated with atopic dermatitis. Jabryus 200mg Tablet is used to treat patients with moderate-to-severe atopic dermatitis or atopic eczema, a chronic skin disease.
Inform your doctor if you're allergic to Abrocitinib, lactose, or any of the ingredients present in the medicine. Consult your doctor if you have a serious infection (tuberculosis) or severe liver problem before using the medicine. It is recommended that you inform your doctor if you are using any immunosuppressant or any other medicine. Inform your doctor if you have a plan to vaccinate or have been recently vaccinated. Consult your doctor if you have a blood clot in the vein of the legs or lungs, a heart problem, or cancer.
Your doctor may advise you to do a blood test. The safety and efficacy of the medicine in children below 12 years of age have not been established. Inform your doctor if you are a patient who is at the age of 65 years or above, it may increase the risk of infection, heart attack and certain types of cancer in such patients.
Uses of Jabryus 200mg Tablet
- Treat moderate-to-severe atopic dermatitis in adults
Therapeutic Effects of Jabryus 200mg Tablet
Jabryus 200mg Tablet is a Janus kinase inhibitor that helps to reduce the activity of the enzyme Janus kinase, which is involved in inflammation. Therefore, it helps to improve the skin condition related to atopic dermatitis in patients.
Interaction of Jabryus 200mg Tablet with other drugs
Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional or vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Jabryus 200mg Tablet and can cause undesirable side effects.
More Information about Jabryus 200mg Tablet
- Store at 25°C
- Keep children away from the sight and reach of this medication.
How to consume Jabryus 200mg Tablet
Always use this medicine as exactly prescribed by your doctor. Depending on the condition being treated, your physician decides the dose, dosage, and frequency of this medicine. Do not chew, crush or dissolve the tablets. Swallow the tablets whole with water.
Safety Advice for Jabryus 200mg Tablet
Breast Feeding
It is unknown whether Jabryus 200mg Tablet is excreted in breast milk. So, before starting the treatment, inform your doctor if you are breastfeeding. Consult your doctor for more information.
Alcohol
It is unknown whether consuming alcohol while taking a Jabryus 200mg Tablet is safe. Please speak with your physician before using the medicine.
Liver
Inform your physician about any underlying liver disorders before taking Jabryus 200mg Tablet, as this medicine may not be given to patients who have a severe liver disorder.
Lungs
It is unknown whether the Jabryus 200mg Tablet is safe for patients with lung problems. Inform your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.
Driving
It is unknown whether Jabryus 200mg Tablet alters driving ability. However, if you experience side effects like tiredness or drowsiness, avoid driving and using machines.
Pregnancy
It is unknown whether the Jabryus 200mg Tablet is harmful to the unborn baby. Notify your healthcare professional if you are pregnant planning to have a baby or think you might be pregnant.
Side Effects of Jabryus 200mg Tablet
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.
Common
- Feeling sick in the stomach (nausea)
- Cold sores
- Vomiting
- Upper abdominal pain
- Dizziness
- Acne
- Increase the blood creatine phosphokinase enzyme level.
Word of Advice
Drinking enough water is recommended to compensate for the water loss during vomiting. It is recommended to avoid eating junk or oily foods, which can worsen the adverse effects of the drug in patients. Applying a cold compress may reduce the pain and inflammation caused by the cold sores. Consult your doctor if you are going for a blood test; the medicine can interfere with the results obtained by the patients. It is recommended to lie down and take a few minutes of rest until the dizziness passes.
FAQs about Jabryus 200mg Tablet
Q1.
Can I take a Jabryus 200mg Tablet if I have tuberculosis?
No, it is recommended to speak with your doctor if you have a tuberculosis infection. You can also speak with your doctor to perform a tuberculosis screening to ensure the safe use of the drug.
Q2.
Can I take a blood test while using the Jabryus 200mg Tablet?
Consult your doctor if you are going for a blood test; the medicine can interfere with the results obtained by the patients. It may raise the creatine phosphokinase level in the blood.
Q3.
Is Jabryus 200mg Tablet safe for elders?
Inform your doctor if you are a patient who is at the age of 65 years or above; it may increase the risk of infection, heart attack, and certain types of cancer in such patients.
Fact Box of Jabryus 200mg Tablet
Molecule name: Abrocitinib
| Therapeutic class: Selective immunosuppressants |
| Pharmacological class: Tyrosine kinase inhibitor | Indications: Treat moderate-to-severe atopic dermatitis in adults |
References
Pfizer Manufacturing Deutschland GmbH, European Medicines Agency (EMA), [Revised on 18 July 2024] [Accessed on 21 May 2024], QRD Human Product Information Template (medicines.org.uk)
Sanofi-aventis,. US Food and Drug Administration, FDA [Revised on Jan 2022] [Accessed on 21st May 2024], https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213871s000lbl.pdf
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that experts, accurate and trustworthy, review. The information and contents of this website are for informational purposes only. They are not intended to substitute for professional medical advice, diagnosis, or treatment. Please seek your doctor's advice and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Dr. Vijayalakshmi N.
BDS
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 31 Mar 2026 | 09:29 AM (IST)
Want to know more?
Read Our Editorial Policy
